Systemic lysis protects against the effects of platelet activation during coronary thrombolysis.

Systemic lysis may protect against the platelet activation and ongoing thrombosis associated with coronary thrombolysis. To address this hypothesis, we compared urokinase and tissue-type plasminogen activator (t-PA) given intravenously in a chronic, canine model of coronary thrombosis. T-PA 10 micro...

Celý popis

Podrobná bibliografie

Vydáno v:	J Clin Invest
Hlavní autoři:	Fitzgerald, D J, Hanson, M, FitzGerald, G A
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Clinical Investigation 1991
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295678/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1939647/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115471
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!